Expect off days (and dont panic) Some days youll feel super motivated
[1][3] Symptoms are dose-dependent : they increase as the dose steps up and are most common in the first few weeks at each new level
In-vitro models and readouts GHS-R1a couples principally to Gq, so inositol phosphate accumulation and intracellular calcium mobilization are the direct readouts, with recombinant lines expressing human GHS-R1a as the usual system
There are no cardiovascular outcome data, no data on weight regain after discontinuation of cagrilintide monotherapy beyond the 6-week off-treatment follow-up in Lau et al., and no data in adolescents, pregnancy, or renal or hepatic impairment
Pivotal trials: what the NEJM data show Semaglutide STEP-1 (2021) and SELECT (2023) STEP-1 (Wilding et al., NEJM 2021) randomized 1,961 adults over 68 weeks on semaglutide 2.4 mg/week
Collectively, the systems summarized in Table 2 demonstrate that the metabolic peptide landscape beyond incretins is rich in validated biology but limited in translational follow-through